SponsorsThe following are the sponsors and partners supporting the ChinaBio® Investor Forum 2011 - Jinan. Our thanks to all of these top-tier organizations for helping make this event possible. For more information on how you can sponsor this or other ChinaBio's events, please contact Tom Wu. Gold Sponsors
Suzhou BioBay is located in southwest of Suzhou Industrial Park, and is the key driver of life science innovation for Suzhou Industrial Park. Suzhou Industrial Park is has built into a garden city and modern high-tech city. More than 200 high-tech innovative companies covering drug discovery, diagnostic, medical device and CRO/CMO have been located in BioBAY, as well as Cold Spring Harbor Asia Conference Center, and 5000 scientists and professionals have come to join this dynamic innovative community. www.biobay.com.cn
Foley is a highly regarded, international law firm providing client-focused, industry-specific services that result in high-value legal counsel for our clients. Our practice areas encompass the full range of corporate legal services. With an office located in Shanghai, the attorneys of Foley’s China Practice are well positioned to assist U.S., Asian, and European clients with the complex matters that arise when doing business in or related to Greater China. From IP procurement and technology transfer to M&A due diligence, count on Foley’s experience and our cultural and business connections in China to help you stake you claim. www.foley.com
Morrison & Foerster’s Life Sciences Practice is comprised of more than 160 attorneys dedicated to serving life sciences companies, research institutions, and the venture capital funds and investments banks that finance them. Morrison & Foerster is a global law firm offering services in corporate finance, mergers & acquisitions, patent strategy and prosecution, collaborations and licensing agreements, trade secret litigation and counseling, employment and labor, and commercial, intellectual property and securities litigation. With offices in Shanghai, Beijing, and Hong Kong, as well as Tokyo, Europe and the United States, we are uniquely positioned to assist life sciences entities around the world. please visit www.mofo.com.
Pfizer has been operating in China since the early 1980's committed to improving the health of the Chinese people and contributing to China's overall prosperity. Pfizer has built on this legacy by introducing innovative, relevant medicines and investing in doctor and patient educational programs. Furthermore, Pfizer contributes to China's scientific and medical development by including China in our global R&D projects. In recognition of the highly-skilled and talented scientists in China, Pfizer established its China Research and Development Center in Shanghai in 2005. The center is staffed with more than 200 Pfizer colleagues supporting various aspects of Pfizer's global R&D efforts. www.pfizer.com Silver Sponsors
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. www.merck.com
OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm, with over $5 billion in assets under management. Since inception of its private equity investment activities in 1993, OrbiMed has successfully invested in over 100 private companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes approximately 30 experienced professionals with backgrounds in science, medicine, industry, finance and law. OrbiMed’s professionals work together using a collaborative, team-oriented approach to support our portfolio companies, which has earned OrbiMed a reputation as a capital provider of choice for life sciences companies of all stages. OrbiMed has created the first pan-Asia healthcare and life sciences-dedicated venture capital fund, with close to $200M under management. OrbiMed’s headquarters are in New York City and has offices in Shanghai and Mumbai. www.orbimed.com Official Partners
BayHelix is an organization of leaders of Chinese origin in the global life sciences and healthcare community. We aspire to shape the growth of the life sciences and healthcare industry around the Pacific Rim and beyond, foster and create business opportunities, supply and nurture the leaders for the community, and network and share information and experience. BayHelix is a non-profit organization and its membership is by invitation only. www.bayhelix.org
BioCentury Publications, Inc., www.biocentury.com provides essential biopharma industry intelligence from five offices in the U.S. and Europe. For more than 18 years, a global audience of biotech and pharmaceutical executives and investors has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company's publications, data products and collaborative industry conferences in the U.S., Europe and Asia. BioCentury's titles include the flagship BioCentury, the Bernstein Report on BioBusiness; SciBX: Science-Business eXchange, a translational science joint publishing venture with Nature Publishing Group; and BioCentury Extra, online daily news covering breaking developments BioCentury also markets its BCIQ: BioCentury Online Intelligence, an online business intelligence resource. In September 2010, the company launched BioCentury This Week, the first weekly biotech public affairs TV program to be broadcast in major U.S. television markets, a partnership with the Gannett-owned CBS affiliate W*USA Channel 9 in Washington, D.C. The BioCentury This Week TV show website continuously streams TV content at www.biocentury.com.
Business Wire is a trusted partner to thousands of Health, Medical, Biotech and Pharmaceutical companies and organizations throughout the world, delivering more corporate news releases from more sources to more destinations than any other service. Business Wire's news wire circuits enable you to target your news to select audiences based on your geographic and industry market needs. Business Wire is the only commercial news wire with full-carriage access to all of the world's leading news agencies, including the Associated Press, Agence France-Presse, Dow Jones, Reuters, Jiji Press, Interfax and more. We can send your news to virtually any media market in the world with distribution to more than 150 countries in dozens of local languages. From delivery to audiences in a single city to comprehensive worldwide coverage including translations, Business Wire offers you an easy, one-stop solution. www.businesswire.com VC Partners
Fidelity Asia Ventures (FAV) is the Asian venture capital arm of FIL Limited, part of the global Fidelity Investments organization. Fidelity Investments is one of the largest mutual fund organizations in the world, managing assets in excess of $1.5 trillion globally.
IDG Capital Partners is a China-focused investment firm with over US$3.8 billion and RMB3.5 billion capital under management. Our offices are located in Hong Kong, Beijing, Shanghai, Guangzhou, Shenzhen, Silicon Valley, and Boston.
Since its establishment in 1990, JAFCO Asia has grown to become a leading brand in the venture capital industry in the Asia Pacific region. Currently, JAFCO Asia has offices in Singapore, Hong Kong, Taipei, Seoul, Beijing and Shanghai.
Lilly Ventures is the venture capital arm of Eli Lilly and Company, a leading innovation-driven pharmaceutical company. Our primary goal is to facilitate the success of companies in our areas of focus through early to expansion stage investments and value-adding resources. Mingly China Growth Fund is a private equity fund formed in 2006 to make critical growth and expansion stage investments in China. The Fund Management Team and its Advisors include a collaboration of successful and experienced U.S. and Chinese investment professionals Demonstrated ability to identify sector leaders early and get closely engaged with founders Deep and growing pipeline with active processes to monitor companies, Hands-on operating experience to help transform companies, Global network of contacts to assist with technology, sales and marketing and management expertise, and Both Foreign Currency Fund and RMB Fund to meet the funding needs of various companies. www.mcgf.com.cn
Morningside is a diversified investment group founded in 1986 by the Chan family of Hong Kong. The Chan family founded the Hang Lung Group in Hong Kong in 1960. Morningside engaged primarily in private equity and venture capital investments. The group has investments in North America, Europe, across Asia-Pacific, and since 1992, in Mainland China. Morningside was one of the earliest institutional investors in China's internet industry and in recent years has been a leader in China's emerging biotechnology sector. In China's media sector, Morningside has been active in both outdoor and print media. www.morningside.com.cn
Mustang Ventures is a China-focused venture firm investing in early stage companies that leverage China’s large pool of intellectual talent, burgeoning domestic market, attractive cost structure, and / or proven export capability. Our team combines local investment experience, senior operating leadership and a global network that we leverage to help guide strong entrepreneurs to market success. Mustang’s partners bring together more than 40 years of operating experience and 10 years of investing experience. Our investing team is led by Rob McCormack, who has completed more than 25 investments in private companies while at Trident Capital and Integral Capital Partners, and our operating team by Leonard Liu, who brings more than 30 years experience in the IT industry, building teams and scaling operations at IBM, Acer, Cadence Design Systems, Walker Interactive Systems, ASE and Augmentum – three of which he grew to sales greater than $1 billion. Mustang has a strategic relationship with Trident Capital of Palo Alto, California. We work closely with our portfolio companies in all aspects of company building. From conceptualization of an idea to building a large and profitable business, we rely on our operational and investment expertise to work with entrepreneurs in building world class organizations. www.mustangvc.com
OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm, with over $5 billion in assets under management. Since inception of its private equity investment activities in 1993, OrbiMed has successfully invested in over 100 private companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes approximately 30 experienced professionals with backgrounds in science, medicine, industry, finance and law. OrbiMed’s professionals work together using a collaborative, team-oriented approach to support our portfolio companies, which has earned OrbiMed a reputation as a capital provider of choice for life sciences companies of all stages. OrbiMed has created the first pan-Asia healthcare and life sciences-dedicated venture capital fund, with close to $200M under management. OrbiMed’s headquarters are in New York City and has offices in Shanghai and Mumbai. www.orbimed.com
In Chinese, “Qiming” literally means starting point and light, purporting the beginning of a new day. Headquartered in Shanghai, Qiming Ventures is dedicated to become a leading venture capital enterprise, devoting to the risk investment to Chinese scientific fields along with its American Ignition Partners. Currently, Qiming Ventures has over $500 million under management; together with its affiliate Ignition Partners, they manage more than $2.5 billion venture capital funds globally. Investment team of Qiming Ventures has rich expertise, enterprise operation practices and investment management experience at home and abroad; Qiming Ventures provides finance to experienced entrepreneurs and businesses with stable profit models, hoping to assist Chinese entrepreneurs to create enterprises with business volumes of billion US $. Qiming Ventures is active to invest in the following sectors:
WI Harper Group works with entrepreneurs who target growth opportunities in Greater China as a key objective for their business. WI Harper pioneered the concept of building a business bridge across the Pacific Ocean for early stage IT and life sciences companies. Since 1996, we have backed over 90 emerging companies in China, Taiwan and the United States, resulting in 15 IPOs and a number of M&A transactions. Our investment professionals in Beijing, San Francisco and Taipei manage over $400M in assets. WI Harper currently manages six funds totaling over US$400 million from its headquarters in San Francisco and branch offices in Beijing, Taipei, and Singapore. WI Harper's portfolio includes over 90 companies in high-growth areas of information technology and life sciences. WI Harper's list of successful portfolio companies currently include examples such as Focus Media (NASDAQ: FMCN), ISSI (NASDAQ: ISSI), iKang, DivX (NASDAQ: DIVX), Commerce One, Bridge Pharmaceutical, Cardiva Medical, PC Home, Kuro, Silicon Motion (NASDAQ: SIMO), Beijing Xinwei, Verisilicon, China Broad Media, MAXTHON, HomeE, Panorama Stock, 3G Portal, Mapbar and Laszlo etc. The firm's previous investments include with companies such as Creative Technology, CommerceOne, Intraware, S3, ISSI and many other public companies. www.wiharper.com Supporting Partners
BIOCOM is a leading biotechnology industry association with over 550 leading life science companies from Southern California as members. BIOCOM's initiatives focus on capital formation, public policy, resource development and scientific discovery and development. They have recently launched a special program to educate and connect U.S.-based life science companies with low cost resources and services available in China. www.biocom.org
Chinese-American BioPharmaceutical Society (CABS) is a not-for-profit, non-political, non-religious professional organization headquartered in San Francisco, California. With the rapid development of bio/pharmaceutical industry in China, more and more people, regardless of their ethnic backgrounds, are looking toward China for business and scientific opportunities. Recognizing this trend, CABS was established not only to educate the public with the progress in biotech and pharmaceutical fields, but also to serve the Bio/Pharmaceutical professionals who are either with Chinese heritage or with professional interests in China. The majority of CABS members are Chinese scientists, entrepreneurs and students/postdocs in biomedical sciences, working in San Francisco Bay Area bio/pharmaceutical industries, universities, and research institutes. The CABS membership is open to the public. www.cabsweb.org
The Chinese Biopharmaceutical Association (CBA) is a non-profit organization made up of professionals who have an interest in bio-pharmaceutical research and/or technology development. CBA was established in 1995 and its headquarters are located in the State of Maryland, which is adjacent to the U.S. capital city of Washington D.C. The majority of CBA members are Chinese scientists, researchers, or professors. They work in government agencies, universities, research institutes as well as in the biotechnology and pharmaceutical industries. Some are conducting pioneering research with the National Institutes of Health (NIH), whereas others are directly involved in the government regulatory process as officers of the Food and Drug Administration (FDA) or in the field of intellectual property as patent attorneys or as patent examiners with the Patent and Trademark Office (PTO). www.cba-usa.org Cyagen Biosciences was established to develop technologies in stem cell research, genetic engineering and transgenic animal research to serve the growing needs from life sciences labs and drug discovery companies. The principals of Cyagen consist of world-class scientists, senior industry experts and professional managers from both the U.S. and China. Cyagen's 1600 square meter main R&D and production facility is located in the Science City on the outskirt of Guangzhou, encompassing a laminar flow ultra-clean cell culture lab built to GMP standard, a molecular biology lab, and an animal barrier facility housing mice and rats intended for transgenic and gene knockout research. The business philosophy of Cyagen is to create a competitive advantage by marrying cutting-edge technologies in the U.S. with cost effectiveness R&D in China, and to use this advantage to bring top-quality reagents, tools and services to researchers around the world at favorable prices. www.cyagen.com Guangzhou Biotechnology Center (namely Biomedical work group of Guangzhou Municipal Government) under the jurisdiction of the Biotechnology Steering Group and the Sciences &Technology Bureau of Guangzhou Municipal Government is a service agency specializing in biotechnology and medicine industry. Its key missions are to develop the biotechnology and medicine industry of Guangzhou and to accelerate the transfer of S&T achievements and parallel cooperation and exchange. www.gzbio.net
Hong Kong Science and Technology Parks Corporation (HKSTP) is a statutory body set up by the Government of the Hong Kong SAR to promote and facilitate the transformation of Hong Kong into Asia’s hub for technology innovation. The Corporation supports a number of technology industries engaging in cutting-edge research and development, including the Life Science and Biotechnology industries, and offers a comprehensive range of facilities and services to address the needs of companies at various stages of development. www.hkstp.org
Lychee Group is a media company specializing in the organization of high-end business-to-business events for China's life sciences industry. We have launched some of the highest-profile events in China including, “CHINATRIALS: Global Clinical Development Summit” and “China Healthcare Investment Conference,” both the largest events in China of their kind. Our mission is simple: create the best, most innovative events to provide our attendees with the latest business information and the greatest opportunity to network with peers and new potential business partners. www.lycheegroup.com
Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) is a 501(C) (3) nonprofit organization founded in early 2002 by professionals and scholars from local Chinese community in San Diego. We invite all scholars, students and professionals with any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry to join us as members of SABPA. www.sabpa.org The Sino-American Pharmaceutical Professionals Association (SAPA) was founded in 1993 as a non-profit organization with its headquarters in the Greater New York area (NJ/NY/CT). SAPA has grown rapidly to become one of the most active and well-recognized professional organizations in the United States with over 4000 members. SAPA's missions are to facilitate the advancement of pharmaceutical science and biotechnology, to contribute to public health education, to foster personal and professional career development, and to promote scientific exchange and business cooperation between the USA and China. In addition to the Greater New York area, SAPA has established regional chapters in New England (SAPA-NE), Greater Philadelphia (SAPA-GP) and West Coast (SAPA-WEST), as well as Shanghai Club (SAPA-Shanghai). www.sapaweb.org Media Partners
Bioon is the leading life science portal in China. And professional registered members have more than 500 thousand; special 70% members are the master's -and doctoral qualifications. Our enterprises’ customers are more than 11 thousand, such as Invitrogen, Promega, Qiagen, Sigma, Pall. As the leading service- provider in China, we are committed to enhance the competition of our customers in life sciences. The following pipelines are our mature businesses: (1) www.bioon.com commitment to the field of life sciences media and brand promotion; (2) www.bioon.com.cn focused on our customers’ products -promotion, display and rankings, such as equipments, consumables, reagents and antibodies; Addition, we collected and sorted the serial of databases -including China lab database, professor database and region -based registered members database. These databases are the strong support and tool for customers marketing activity and marketing survey & analysis. Now, Bioon.com has become the preferred options to life sciences’ customers for professional seminar & training, targeting product promotion, brand -improvement and marketing survey & analysis. of professional customers in China. www.bioon.com
China is already the fastest growing market in the world for pharmaceuticals. Now, after billions of dollars of government and private investment, China is transforming itself into a world leader in biotechnology. ChinaBio® Today focuses exclusively on the rapidly evolving biotech industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events, as well as global issues affecting the China market. www.chinabiotoday.com
Essinova Life Science TV is an Internet TV channel and community for life sciences, biopharma, medical devices and healthcare services industries. We produce and publish executive interviews, corporate videos, investor pitches, product demos, science and technology visualization, event videos and other multimedia content serving companies and organizations in business for health. Our program brings fresh perspectives, candid insights, unique stories and practical expertise to our viewers. Our creative and broadcast-quality productions showcase innovative ideas, technologies, products and methodologies for our clients more compellingly than any conventional media. We help our clients and members deliver their messages to their desired audience efficiently and cost-effectively, utilizing the power of rich and social media, and leveraging our growing network of partnerships. www.essinova.com Healthcare Executive, established in December 2008, is a monthly magazine focused on the pharmaceutical industry. It is hosted by Chinese Pharmaceutical Enterprises Association and ZhuoXin Medical Media Group and supported by a team consists of senior medical media people, and positioned to a “the news and resource center in the pharmaceutical industry”. Its readers are mostly entrepreneurs, investors, and people work at the supervision and services organizations in this industry.
Interfax China is a member of the Interfax International Information Group. Interfax Group provides news and other information products that are essential for decision-makers in politics and business. Since early 1990s, Interfax has been the main provider of up-to-date news from Russia and countries of the former Soviet Union. We are the most frequently quoted source of information on the region. Over the past few years, Interfax has also become a leading provider of political and business news from China and emerging markets of Central Europe. www.interfax.cn
PharmAsiaNews.com is an online portal providing news and analysis on regulatory, legal and financial developments affecting pharmaceutical, biologics and medical device manufacturers doing business in China, India, Japan and other nations of the Pacific Rim. PharmAsiaNews.com leverages the editorial excellence of "The Pink Sheet" -- the leading information source for the U.S. pharmaceutical industry since 1939. Subscribers get original on-the-ground reporting from news bureaus across Asia, guest columns, exclusive interviews, news summaries, English translation summaries of Chinese- and Japanese-language news, and aggregated content from around the globe. Free 30-day trial. www.PharmAsiaNews.com Pharma Connections Worldwide® is a professional business networking and consulting company focused in the Pharmaceutical, Biotechnology, Medical Devices and Life Sciences industry. With contacts from over 130 Countries we are truly global. Visit these links for more information on our services and opportunities. www.pharmaconnections.com For more sponsorship information , please contact:
|
CBMS LOGIN
Organizer  Hosted by  Sponsors & Partners Gold Sponsors
Silver Sponsors
Official Partners
VC Partners
Supporting Partners
Media Partners
|
Copyright © 2013, ChinaBio® LLC - ChinaBio is a registered trademark of ChinaBio® LLC